DHEA Replacement in Adrenal Insufficiency
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Recent double-blind, randomized crossover studies have demonstrated significant beneficial effects of dehydroepiandrosterone (DHEA) replacement on mood, sexuality, and health-related quality of life (HRQoL) in patients with adrenal insufficiency (1, 2). HRQoL in patients with both primary and secondary adrenal insufficiency is significantly impaired (3, 4). In a cohort of 88 Addison patients, Lovas et al. (3) found significantly impaired HRQoL scores, similar to those usually seen in chronic heart failure, with a significant impact on the incidence of disablement pensions (41% in Addison’s vs. only 17% in the general population for ages 40–67 yr; P < 0.001). In the March issue of the JCEM, Lovas et al. (5) have published the results of a 9-month, randomized, parallel group clinical trial investigating the effects of DHEA replacement in women with adrenal failure, failing to find significant improvements in HRQoL during DHEA administration. However, this outcome could have been easily predicted because their study is severely underpowered. Statistical power calculations show that a parallel study aiming to obtain significant effects similar to those reported by recent crossover studies (1, 2), which used 24–39 patients, would require the inclusion of at least 100 patients to ascertain adequate statistical power. Power calculations are of particular importance for parallel studies using HRQoL measurements, because HRQoL scores generally show broad interindividual variability. In addition, the study presented by Lovas et al. (5) is the result of a multicenter approach, reporting the results of DHEA treatment in 15 patients from five different centers. For a reliable power calculation, this would push the number needed to treat beyond even 100 because a multicenter study necessarily shows a greater variability in results, again, in particular with regard to HRQoL scores. Results from underpowered studies are definitely noteworthy if they show significant effects, like the recent study by Johannsson et al. (6) on DHEA replacement in women with secondary adrenal failure. However, negative results from an underpowered study like the paper by Lovas et al. (5) do not contribute to furthering our knowledge in this field. By contrast, this paper may adversely affect it because it will be cited as negative evidence against DHEA replacement in adrenal insufficiency, despite its lack of statistical power. Results from an adequately powered parallel trial on DHEA replacement including 106 patients with primary adrenal insufficiency will hopefully be available soon; preliminary results published in abstract form (7, 8) reported significant improvements in HRQoL scores in both men and women with primary adrenal failure. The scientific community needs the results from well-designed, adequately powered, larger scale studies to securely establish the role of DHEA in the standard replacement regimen for adrenal insufficiency.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A 9-month, parallel group trial of DHEA replacement in 39 patients showing no benefit in health status (25) may have been underpowered (26).”
From Long-Term DHEA Replacement in Primary Adrenal Insufficiency: A Randomized, Controlled Trial (2008) · cites this paper as [26]
Citations
Cites
Dehydroepiandrosterone Replacement in Women with Adrenal Insufficiency
Arlt, W., Callies, F., van Vlijmen, J. C., Koehler, I., Reincke, M., Bidlingmaier, M., Huebler, D., Oettel, M., Ernst, M., Schulte, H. M., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909303411401 · Cited by 644
Self-citationHunt, P. J., Gurnell, E. M., Huppert, F. A., Richards, C., Prevost, A. T., Wass, J. A. H., Herbert, J., & Chatterjee, V. K. K. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.12.7022 · Cited by 386
Decreased psychological well‐being in adult patients with growth hormone deficiency
Rosén, T., Wirén, L., Wilhelmsen, L., Wiklund, I., & Bengtsson, B. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb02452.x · Cited by 316
Subjective health status in Norwegian patients with Addison’s disease.
Løvås, K., Loge, J. H., & Husebye, E. S. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01466.x · Cited by 256
Phenotypes Associated with SHOX Deficiency
ROSS, J. L., Scott, C. I., Marttila, P., Kowal, K., Nass, A., Papenhausen, P. R., Abboudi, J., Osterman, L. A., Kushner, H., Carter, P., et al. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.12.5674 · Cited by 223
Johannsson, G., Burman, P., Wirén, L., Engström, B. E., Nilsson, A. G., Ottosson, M., Jonsson, B., Bengtsson, B.-Å., & Karlsson, F. A. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.5.8494 · Cited by 175
Løvås, K., Gebre-Medhin, G., Trovik, T. S., Fougner, K. J., Uhlving, S., Nedrebø, B. G., Myking, O. L., Kämpe, O., & Husebye, E. S. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020769 · Cited by 144
Rosenfeld, R. G. (2001) · PubMed · doi:10.1210/jcem.86.12.eg1201.8186 · Cited by 18
Research works printed but not linked: 1
- Gurnell, 2002, A long term trial of DHEA replacement in Addison’s disease, 33
Cited by
Premature Mortality in Patients with Addison’s Disease: A Population-Based Study
Bergthorsdottir, R., Leonsson-Zachrisson, M., Odén, A., & Johannsson, G. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0076 · Cited by 490
Long-Term DHEA Replacement in Primary Adrenal Insufficiency: A Randomized, Controlled Trial
Gurnell, E. M., Hunt, P. J., Curran, S. E., Conway, C. L., Pullenayegum, E. M., Huppert, F. A., Compston, J. E., Herbert, J., & Chatterjee, V. K. K. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1134 · Cited by 189
DHEA, Important Source of Sex Steroids in Men and Even More in Women
Labrie, F. (2010) · Progress in Brain Research · doi:10.1016/s0079-6123(10)82004-7 · Cited by 183
Dehydroepiandrosterone and ageing
Arlt, W. (2004) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2004.02.006 · Cited by 129
Self-citationMerza, Z., Rostami‐Hodjegan, A., Memmott, A., Doane, A., Ibbotson, V., Newell‐Price, J., Tucker, G. T., & Ross, R. J. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02544.x · Cited by 98
Metadata
- Authors
- Arlt, W., & Allolio, B.
- Affiliations
- Queen Elizabeth Hospital Birmingham (GB)
- University of Würzburg (DE)
- Corresponding author
- Arlt, Wiebke
- ORCID
- Arlt, Wiebke
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2003-08-01
- Volume
- 88
- Issue
- 8
- Pages
- 4001-4004
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2038878475
- Semantic Scholar
- 4b33fed07e107fe8894f3a4ddc5c5aa3157d4980
- Cited by
- 15
- References
- 8
- Citations by year
- 2021: 1 · 2015: 2
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- adrenal insufficiency, Addison's disease, health-related quality of life, statistical power, secondary adrenal insufficiency, women, disability pension, number needed to treat
- MeSH terms
- Adrenal Gland Diseases, Adult, Dehydroepiandrosterone, Female, Humans, Hormone Replacement Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: DHEA Replacement in Adrenal Insufficiency. https://app.cochat.ai/papers/10.1210/jc.2003-030534
- The paper
- Arlt, W., & Allolio, B. (2003). DHEA Replacement in Adrenal Insufficiency. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2003-030534
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.